1. N -Acyl Dopamines Induce Apoptosis in Endometrial Stromal Cells from Patients with Endometriosis.
- Author
-
Gamisonia AM, Yushina MN, Fedorova-Gogolina IA, Akimov MG, Eldarov CM, Pavlovich SV, Bezuglov VV, Gretskaya NM, Sukhikh GT, and Bobrov MY
- Subjects
- Caspase 3 metabolism, Caspase 9 metabolism, Cell Survival drug effects, Cells, Cultured, Dopamine pharmacology, Endometriosis pathology, Endometrium drug effects, Female, Humans, Membrane Potential, Mitochondrial drug effects, Reactive Oxygen Species metabolism, Signal Transduction drug effects, Stromal Cells drug effects, Apoptosis drug effects, Arachidonic Acids pharmacology, Dopamine analogs & derivatives, Endometriosis metabolism, Endometrium metabolism, Stromal Cells metabolism
- Abstract
Endometriosis is characterized by the formation and development of endometrial tissues outside the uterus, based on an imbalance between proliferation and cell death, leading to the uncontrolled growth of ectopic foci. The potential target for the regulation of these processes is the endocannabinoid system, which was found to be involved in the migration, proliferation, and survival of tumor cells. In this paper, we investigated the effect of endocannabinoid-like compounds from the N -acyl dopamine (NADA) family on the viability of stromal cells from ectopic and eutopic endometrium of patients with ovarian endometriosis. N -arachidonoyldopamine, N -docosahexaenoyldopamine, and N -oleoyldopamine have been shown to have a five-times-more-selective cytotoxic effect on endometrioid stromal cells. To study the mechanisms of the toxic effect, inhibitory analysis, measurements of caspase-3/9 activity, reactive oxygen species, and the mitochondrial membrane potential were performed. It was found that NADA induced apoptosis via an intrinsic pathway through the CB1 receptor and downstream serine palmitoyltransferase, NO synthase activation, increased ROS production, and mitochondrial dysfunction. The higher selectivity of NADA for endometriotic stromal cells and the current lack of effective drug treatment can be considered positive factors for further research of these compounds as possible therapeutic agents against endometriosis.
- Published
- 2021
- Full Text
- View/download PDF